Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects.

Seminars in Cancer Biology
Haroon KhanMohammad Amjad Kamal

Abstract

The conventional therapies for cancer have a major concern of poor accessibility to tumor tissues. Furthermore, the requirement of higher doses and non-selective nature of therapeutic are associated with a range of adverse drug reactions (ADRs). However, flavonoids are documented to be effective against various types of cancer, but they are not evaluated for their safety profile and tumor site-specific action. Low solubility, rapid metabolism and poor absorption of dietary flavonoids in gastrointestinal tract hinder their pharmacological potential. Some studies have also suggested that flavonoids may act as pro-oxidant in some cases and may interact with other therapeutic agents, especially through biotransformation. Nanocarriers can alter pharmacokinetics and pharmacodynamic profile of incorporating drug. Moreover, nanocarriers are designed for targeted drug delivery, improving the bioavailability of poorly water-soluble drugs, delivery of macromolecules to site of action within the cell, combining therapeutic agents with imaging techniques which may visualize the site of drug delivery and co-delivery of two or more drugs. Combining two or more anti-cancer agents can reduce ADRs and nanotechnology played a pivotal role in this...Continue Reading

References

Mar 18, 1994·Science·R GrefR Langer
Jul 1, 1995·European Journal of Drug Metabolism and Pharmacokinetics·W SchubertT Hedner
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·R K Jain
Jun 6, 2002·Critical Reviews in Therapeutic Drug Carrier Systems·Alexander V Kabanov, Valery Yu Alakhov
Oct 22, 2003·Pharmaceutical Research·Seong Hoon JangJessie L S Au
Dec 18, 2003·Drug Discovery Today·Sanjeeb K Sahoo, Vinod Labhasetwar
Feb 4, 2005·Journal of Chemotherapy·L CattelF Dosio
Oct 26, 2005·Drug Discovery Today·Kewal K Jain
Dec 8, 2005·Nature Biotechnology·Cameron C LeeFrancis C Szoka
Aug 11, 2006·Nature Reviews. Cancer·Ruth Duncan
Feb 9, 2007·International Journal of Pharmaceutics·Vaithilingam Selvaraj, Muthukaruppan Alagar
Feb 16, 2008·Drug Discovery Today·Sanjeeb K SahooS Krishnakumar
Feb 21, 2008·Journal of Biomedical Materials Research. Part a·Zhongkui HongJoão F Mano
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kwangjae ChoDong M Shin
Jul 3, 2008·Journal of Agricultural and Food Chemistry·O Benavente-García, J Castillo
Jul 26, 2008·Nature Nanotechnology·Dan PeerRobert Langer
Sep 2, 2008·Nature Reviews. Drug Discovery·Mark E DavisDong M Shin
Feb 12, 2009·ACS Nano·Omid C Farokhzad, Robert Langer
Feb 24, 2009·Journal of Agricultural and Food Chemistry·Tarja NurmiSari Voutilainen
Apr 9, 2009·Journal of the American Chemical Society·Sarit S AgastiVincent M Rotello
Apr 22, 2009·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Ana García-LafuenteJosé Alfredo Martínez
Jun 23, 2009·Journal of Pharmaceutical Sciences·Ana I AlvarezGracia Merino
Jun 30, 2009·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·José HureauxThierry Urban
Aug 25, 2009·Advanced Drug Delivery Reviews·Francesca Greco, María J Vicent
Oct 15, 2009·International Journal of Pharmaceutics·C E Mora-HuertasA Elaissari
Oct 17, 2009·International Journal of Pharmaceutics·K Teskac, J Kristl
Oct 20, 2009·Trends in Pharmacological Sciences·Yogeshkumar MalamAlexander M Seifalian
Apr 8, 2010·Mini Reviews in Medicinal Chemistry·Song Gao, Ming Hu
Apr 13, 2010·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·M Wang, M Thanou
Sep 8, 2010·Biophysical Journal·Triantafyllos StylianopoulosRakesh K Jain
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
May 4, 2011·Journal of Food Science·Hugo Palafox-CarlosGustavo A González-Aguilar
Oct 5, 2011·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Aparajita GhoshNirmalendu Das
Nov 19, 2011·Pharmacognosy Reviews·Maheep K ChaharYogesh C Joshi
Feb 4, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Susana Patricia EgusquiaguirreJosé Luis Pedraz
Feb 16, 2012·Chemical Society Reviews·Mahmoud Elsabahy, Karen L Wooley
Feb 23, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fabienne DanhierVéronique Préat
Jun 2, 2012·Drug Discovery Today·Priyambada ParhiSanjeeb Kumar Sahoo
Dec 13, 2012·Pathology Oncology Research : POR·Nechikkad SulfikkaraliRamadas Madhavan Nirmal
Dec 18, 2012·Nature Nanotechnology·Alessandro ParodiEnnio Tasciotti
Jan 16, 2013·Biotechnology Advances·Amit Kumar MittalUttam Chand Banerjee
Jan 22, 2013·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Chandrakantsing PardeshiAbhijeet Sonje

❮ Previous
Next ❯

Citations

Jul 16, 2020·Phytotherapy Research : PTR·Haroon KhanSyed M M Shah
Mar 1, 2020·International Journal of Molecular Sciences·Kristina FerenczyovaMonika Bartekova
Sep 6, 2020·Biomolecules·Malgorzata DobrzynskaEwa Florek
Sep 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Evelyn PeñalozaRafael Garrett
Nov 7, 2019·Biomolecules·Javad Sharifi-RadWilliam C Cho
Aug 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Martina Cebova, Olga Pechanova
May 3, 2020·Current Topics in Medicinal Chemistry·Yusuf HussainAbha Meena
Jan 15, 2020·Current Neuropharmacology·Miryam Nava Catorce, Goar Gevorkian
Dec 2, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mei ZhangNorbert Radacsi
Feb 6, 2020·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jinyun DongJiang-Jiang Qin
Apr 14, 2021·Critical Reviews in Food Science and Nutrition·Abid NaeemZheng Qin
May 1, 2021·Nutrients·Razan J MasadBasel K Al-Ramadi
May 21, 2020·Current Drug Metabolism·Abu BakerMohd Sajid Khan
Jun 26, 2021·Biomaterials Science·Yin ZhongXintao Shuai
Jul 31, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Marjan TalebiSaeed Samarghandian
Aug 8, 2021·International Journal of Molecular Sciences·Waqas AlamCarla Renata Arciola
Oct 29, 2021·Journal of Biomedical Nanotechnology·Jingxin FuXiangtao Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Nanoscience and Nanotechnology
Adeeb ShehzadYoung Sup Lee
International Journal of Nanomedicine
Darshini ShahSanjay Singh
Anti-cancer Agents in Medicinal Chemistry
Alessandro AllegraCaterina Musolino
BioMed Research International
Chiara DianzaniGiuseppina Barrera
© 2021 Meta ULC. All rights reserved